2018
Cesarean Scar Pregnancy, Incidence, and Recurrence
Grechukhina O, Deshmukh U, Fan L, Kohari K, Abdel-Razeq S, Bahtiyar MO, Sfakianaki AK. Cesarean Scar Pregnancy, Incidence, and Recurrence. Obstetrics And Gynecology 2018, 132: 1285-1295. PMID: 30303911, DOI: 10.1097/aog.0000000000002940.Peer-Reviewed Original ResearchMeSH KeywordsAbortifacient Agents, NonsteroidalAdultCesarean SectionCicatrixCombined Modality TherapyCurettageFemaleHumansHysteroscopyMethotrexatePotassium ChloridePregnancyPregnancy RatePregnancy, EctopicRecurrenceTertiary Care CentersUterine Artery EmbolizationUterine Balloon TamponadeWatchful WaitingYoung AdultConceptsCesarean scar pregnancyScar pregnancySubsequent pregnancy outcomeLocal methotrexatePregnancy outcomesTreatment modalitiesRecurrent cesarean scar pregnancyBilateral uterine artery embolizationElectronic medical record reviewYale-New Haven HospitalSubsequent spontaneous conceptionViable intrauterine pregnancyPrior cesarean deliveryMedical record reviewTime of diagnosisUterine artery embolizationPotassium chloride injectionFetal cardiac activityProducts of conceptionIntrauterine pregnancyPregnancy characteristicsSystemic methotrexateExpectant managementMethotrexate therapyArtery embolization
2011
Neoadjuvant and Adjuvant Chemotherapy of Cervical Cancer
McCaffrey R, Bahtiyar M, Kohorn EI, Chambers JT, Schwartz PE, Chambers SK. Neoadjuvant and Adjuvant Chemotherapy of Cervical Cancer. International Journal Of Gynecological Cancer 2011, 21: 535-544. PMID: 21436702, DOI: 10.1097/igc.0b013e31820c4c8d.Peer-Reviewed Original ResearchMeSH KeywordsAdenocarcinomaAdultAntineoplastic Combined Chemotherapy ProtocolsBleomycinCarcinoma, AdenosquamousCarcinoma, Squamous CellChemotherapy, AdjuvantCisplatinFemaleFluorouracilHumansLeucovorinMaximum Tolerated DoseMethotrexateMiddle AgedNeoadjuvant TherapyNeoplasm Recurrence, LocalNeoplasm StagingProspective StudiesSurvival RateTreatment OutcomeUterine Cervical NeoplasmsYoung AdultConceptsLymph nodesRadiation therapyResponse rateSurvival ratePathologic complete response rateCisplatin-based neoadjuvant chemotherapyAdjuvant chemotherapy armComplete response rateConsolidation radiation therapyStage IIB cancerDisease-free survivalHigh-risk featuresPercent of patientsPositive lymph nodesPostoperative radiation therapyChemotherapy response rateAdjuvant casesAdjuvant chemotherapyChemotherapy armChemotherapy eraNeoadjuvant groupNonsquamous histologyNeoadjuvant chemotherapyAdjuvant groupOverall survival